Home › Funds › Eversept Partners, LP › AMN
Eversept Partners, LP position in AMN
AMN HEALTHCARE · Consumer Discretionary
Eversept Partners, LP reported holding 428,531 shares of AMN (AMN HEALTHCARE) in its Q2 2026 13F filing — a position valued at US$13.9M, representing 0.73% of its reported portfolio and ranking #36 among its reported holdings. Eversept Partners, LP has disclosed AMN holdings in 2 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's AMN position evolved
Eversept Partners, LP first disclosed a stake in AMN in Q3 2023 at 50,000 shares (US$4.3M). The position peaked in Q2 2026 at 428,531 shares, worth US$13.9M. Across 2 filings, Eversept Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 428,531 shares valued at US$13.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 50.00K | $4.26M | New |
| Q2 2026 | 428.53K | $13.87M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMN and 13F data
AMN (AMN HEALTHCARE) is a Consumer Discretionary company. 27 other funds we track also report a position in AMN — the largest reported positions include Tributary Capital Management, LLC (US$19.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMN
- Tributary Capital Management, LLC 601.20K sh · $19.46M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held AMN?
Eversept Partners, LP has disclosed AMN holdings in 2 of the last 12 reported quarters, going back to Q3 2023.
What is Eversept Partners, LP's current position in AMN?
As of Q2 2026, Eversept Partners, LP holds 428.53K shares of AMN (AMN HEALTHCARE), valued at $13.87M, representing 0.73% of its reported portfolio and ranking #36.
Has Eversept Partners, LP been buying or selling AMN?
In the latest 13F filing (Q2 2026), Eversept Partners, LP newly opened its position in AMN. The position peaked in Q2 2026 at 428.53K shares.
Which other funds hold AMN?
Other major institutional holders of AMN include Tributary Capital Management, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.